Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET.
The L-type amino acid transporter-1 (LAT1, SLC7A5) is upregulated in a wide range of human cancers, positively correlated with the biological aggressiveness of tumors, and a promising target for both imaging and therapy. Radiolabeled amino acids such as O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET) that...
Main Authors: | Oluwatayo F Ikotun, Bernadette V Marquez, Chaofeng Huang, Kazue Masuko, Miyamoto Daiji, Takashi Masuko, Jonathan McConathy, Suzanne E Lapi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3797081?pdf=render |
Similar Items
-
<sup>89</sup>Zr-Labeled AR20.5: A MUC1-Targeting ImmunoPET Probe
by: Kimberly Fung, et al.
Published: (2020-05-01) -
First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody
by: Denis R. Beckford-Vera, et al.
Published: (2022-03-01) -
Improved image reconstruction of 89Zr-immunoPET studies using a Bayesian penalized likelihood reconstruction algorithm
by: Julian Kirchner, et al.
Published: (2021-01-01) -
89Zr-labeled ImmunoPET targeting the cancer stem cell antigen CD133 using fully-human antibody constructs
by: Kevin Wyszatko, et al.
Published: (2024-03-01) -
Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging
by: Laure Badier, et al.
Published: (2024-06-01)